Title |
Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder
|
---|---|
Published in |
Drug, Healthcare and Patient Safety, February 2009
|
DOI | 10.2147/dhps.s4388 |
Pubmed ID | |
Authors |
Shaker Mousa, Brady, Shaker Mousa, Mousa |
Abstract |
In the past, polycystic ovary syndrome has been looked at primarily as an endocrine disorder. Studies now show that polycystic ovary syndrome is a metabolic, hormonal, and psychosocial disorder that impacts a patient's quality of life. It is extremely important to holistically treat these patients early on to help them deal with the emotional stress that is often overlooked with polycystic ovary syndrome. Early diagnosis and long term management can help control polycystic ovary syndrome so that women can still live a healthy active life and avoid long-term complications such as metabolic syndrome and cardiovascular diseases. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
South Africa | 1 | 25% |
United States | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 159 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 22 | 14% |
Student > Master | 21 | 13% |
Student > Ph. D. Student | 14 | 9% |
Student > Postgraduate | 11 | 7% |
Researcher | 10 | 6% |
Other | 13 | 8% |
Unknown | 68 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 20% |
Nursing and Health Professions | 11 | 7% |
Psychology | 11 | 7% |
Biochemistry, Genetics and Molecular Biology | 9 | 6% |
Unspecified | 4 | 3% |
Other | 19 | 12% |
Unknown | 73 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2020.
All research outputs
#2,233,202
of 25,457,858 outputs
Outputs from Drug, Healthcare and Patient Safety
#13
of 160 outputs
Outputs of similar age
#9,848
of 186,398 outputs
Outputs of similar age from Drug, Healthcare and Patient Safety
#1
of 2 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 160 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,398 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them